Arkolith/Insider Trading/HRTX/Form 4

Rosen David Efraim

10% OwnerHERON THERAPEUTICS, INC. /DE/ (HRTX) · full profile →Form 4 · filed Oct 17, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 15, 2025Conversion(C)946K——30.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 15, 2025Conversion(C)95K—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-004459) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML